Page last updated: 2024-10-27

fluoxetine and Carotid Artery Narrowing

fluoxetine has been researched along with Carotid Artery Narrowing in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, P1
Zhang, X1
Lu, Y1
Chen, C1
Li, C1
Zhou, M1
Lu, Q1
Xu, X1
Shen, G1
Guo, L1

Other Studies

1 other study available for fluoxetine and Carotid Artery Narrowing

ArticleYear
Fluoxetine ameliorates cognitive impairments induced by chronic cerebral hypoperfusion via down-regulation of HCN2 surface expression in the hippocampal CA1 area in rats.
    Pharmacology, biochemistry, and behavior, 2016, Volume: 140

    Topics: Animals; CA1 Region, Hippocampal; Carotid Stenosis; Cerebrovascular Circulation; Cerebrovascular Dis

2016